10.08.2013 Views

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

Het volume van chirurgische ingrepen en de impact ervan op ... - KCE

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>KCE</strong> Reports 113 Volume Outcome 77<br />

DESCRIPTION OF DIFFERENCES IN CHARACTERISTICS ACCORDING TO<br />

THE VOLUME CATEGORY OF THE SURGEON<br />

The majority of surgeons are below the international cut off of 6 interv<strong>en</strong>tions per year.<br />

Three categories were <strong>de</strong>fined below that cut off (1/year: 60 surgeons, 2/year and 3-<br />

5/year). Table 5.29 show that surgeon performing at least 6 pancreatic cancer have a 2year<br />

mortality rate lower than 50%, while surgeons who perform less than 6<br />

procedures per year have a 2-year mortality rate of above 55%. Pati<strong>en</strong>ts who are<br />

treated by low-<strong>volume</strong> surgeons seem a bit ol<strong>de</strong>r and have more co morbidities (i.e.<br />

more pati<strong>en</strong>ts with Charlson score ≥ 3). The highest <strong>volume</strong> surgeons (>10<br />

procedures/year) have <strong>op</strong>erated more pati<strong>en</strong>ts with malignant ne<strong>op</strong>lasm of extrahepatic<br />

bile ducts or ampulla of Vater (which have a better survival rate as se<strong>en</strong> in Table 5.25).<br />

Finally, distribution of the tumour stages among the surgeon categories does not seem<br />

to be related to the <strong>volume</strong>.<br />

Table 5.29: Pancreatic cancer surgery: Differ<strong>en</strong>ces in case-mix and outcomes<br />

by surgeon <strong>volume</strong><br />

Surgeon <strong>volume</strong><br />

1/yr 2/yr 3-5/yr 6-10/yr >10/yr All<br />

Number surgeons 60 23 17 5 4 109<br />

Number stays 60 45 62 42 78 287<br />

G<strong>en</strong><strong>de</strong>r %male 51.7 55.6 56.5 61.9 56.4 56.1<br />

Mean 66.9 65.0 66.5 63.2 63.3 65.0<br />

Age Std 8.6 11.3 9.5 12.2 10.7 10.4<br />

Charlson ≥ 3 % 18.3 17.8 12.9 11.9 2.6 11.8<br />

Charlson<br />

Mean 1.2 1.0 1.1 0.9 0.6 0.9<br />

Std 1.6 1.5 1.4 1.6 0.9 1.4<br />

Severity in<strong>de</strong>x (APR-DRG)<br />

1 % 1.7 2.2 3.2 2.4 1.3 2.1<br />

Principal Diagnosis (MCD)<br />

2 % 10.0 6.7 3.2 9.5 2.6 5.9<br />

3 % 23.3 24.4 14.5 23.8 26.9 22.6<br />

4 % 65.0 66.7 79.0 64.3 69.2 69.3<br />

Duod<strong>en</strong>um tumour % 5.0 2.2 11.3 4.8 6.4 6.3<br />

Extrahepatic bile<br />

ducts or ampulla of<br />

Vater tumour % 16.7 13.3 11.3 14.3 28.2 17.8<br />

Pancreas tumour % 78.3 84.4 77.4 81.0 65.4 76.0<br />

L<strong>en</strong>gth of stay Median 25.5 24.0 21.5 25.0 22.5 23.0<br />

In-hospital +<br />

approximate 30day<br />

mortality % 10.0 6.7 11.3 7.1 6.4 8.4<br />

2-year mortality % 55.0 60.0 59.7 45.2 42.3 51.9<br />

Stage<br />

0-I % 28.9 13.8 26.7 4.2 25.5 22.2<br />

II % 51.1 65.5 57.8 62.5 56.4 57.6<br />

III % 13.3 3.4 11.1 16.7 1.8 8.6<br />

IV % 6.7 17.2 4.4 16.7 16.4 11.6

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!